Global Veterinary Vaccination Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Veterinary Vaccination Market Insights, Forecast to 2034
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
Market Analysis and InsightsGlobal Veterinary Vaccination Market
Global Veterinary Vaccination market is expected to reach to US$ 11540 million in 2024, with a positive growth of %, compared with US$ 10810 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Veterinary Vaccination industry is evaluated to reach US$ 17220 million in 2029. The CAGR will be 6.9% during 2024 to 2029.
The veterinary vaccination market is driven by the increasing awareness of animal health and the growing demand for preventive measures against infectious diseases in animals. Veterinary vaccinations play a crucial role in protecting animals from a wide range of infectious diseases, improving animal welfare, and preventing disease transmission to humans. The rise in pet ownership and the intensification of livestock production contribute to market growth as animal owners and farmers prioritize vaccination as a preventive healthcare measure. Moreover, advancements in vaccine technology, such as the development of recombinant and vectored vaccines, have improved vaccine efficacy and safety for diverse animal species. However, the market also faces challenges, including the need for tailored vaccination programs for different animal populations and the ongoing threat of emerging and evolving pathogens. Additionally, addressing vaccine hesitancy among animal owners and the cost of vaccination in low-income regions can pose obstacles for comprehensive animal health protection. To succeed, companies must focus on research and development to offer innovative and targeted veterinary vaccines, collaborate with veterinary professionals to promote vaccination education, and address the challenges to meet the increasing demand for effective and accessible animal health solutions.
Report Covers
This report presents an overview of global Veterinary Vaccination market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Veterinary Vaccination market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Livestock
Swine
Chicken
Dog & Cat
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Veterinary Vaccination introduction, etc. Veterinary Vaccination Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Veterinary Vaccination
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Veterinary Vaccination Market
Global Veterinary Vaccination market is expected to reach to US$ 11540 million in 2024, with a positive growth of %, compared with US$ 10810 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Veterinary Vaccination industry is evaluated to reach US$ 17220 million in 2029. The CAGR will be 6.9% during 2024 to 2029.
The veterinary vaccination market is driven by the increasing awareness of animal health and the growing demand for preventive measures against infectious diseases in animals. Veterinary vaccinations play a crucial role in protecting animals from a wide range of infectious diseases, improving animal welfare, and preventing disease transmission to humans. The rise in pet ownership and the intensification of livestock production contribute to market growth as animal owners and farmers prioritize vaccination as a preventive healthcare measure. Moreover, advancements in vaccine technology, such as the development of recombinant and vectored vaccines, have improved vaccine efficacy and safety for diverse animal species. However, the market also faces challenges, including the need for tailored vaccination programs for different animal populations and the ongoing threat of emerging and evolving pathogens. Additionally, addressing vaccine hesitancy among animal owners and the cost of vaccination in low-income regions can pose obstacles for comprehensive animal health protection. To succeed, companies must focus on research and development to offer innovative and targeted veterinary vaccines, collaborate with veterinary professionals to promote vaccination education, and address the challenges to meet the increasing demand for effective and accessible animal health solutions.
Report Covers
This report presents an overview of global Veterinary Vaccination market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Veterinary Vaccination market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Segment by Application
Livestock
Swine
Chicken
Dog & Cat
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Veterinary Vaccination introduction, etc. Veterinary Vaccination Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Veterinary Vaccination
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports